Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ocular surface evaluation in treatment-naive ocular hypertension or early open-angle glaucoma patients receiving fixed prostaglandin analog + timolol eye drops
RBR-7mmp6kCompleted
- Sponsor
- Federal University of São Paulo
- Start
- Mar 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in ocular hypertension and open-angle glaucoma (OAG) comparing Latanoprost + timolol, Bimatoprost + timolol and Travoprost + timolol (3 arms). Primary endpoints: Ocular surface evaluation, Schirmer II test and 4 more. Started Mar 2011; status: completed.
02
Drugs
latanoprostbimatoprosttravoprosttimolol
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on RBR-7mmp6k.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7mmp6k.